These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 15181744)
1. [Assessment of apolipoprotein E genotype in Parkinson disease patients with and without dementia]. Jasińska-Myga B; Opala G; Ochudło S; Tustanowski J Wiad Lek; 2004; 57(1-2):20-4. PubMed ID: 15181744 [TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E genotypes in Parkinson's disease with and without dementia. Koller WC; Glatt SL; Hubble JP; Paolo A; Tröster AI; Handler MS; Horvat RT; Martin C; Schmidt K; Karst A Ann Neurol; 1995 Feb; 37(2):242-5. PubMed ID: 7847865 [TBL] [Abstract][Full Text] [Related]
3. Parkinson's disease and apolipoprotein E: possible association with dementia but not age at onset. Parsian A; Racette B; Goldsmith LJ; Perlmutter JS Genomics; 2002 Mar; 79(3):458-61. PubMed ID: 11863377 [TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E epsilon4 and catechol-O-methyltransferase alleles in autopsy-proven Parkinson's disease: relationship to dementia and hallucinations. Camicioli R; Rajput A; Rajput M; Reece C; Payami H; Hao C; Rajput A Mov Disord; 2005 Aug; 20(8):989-94. PubMed ID: 15852364 [TBL] [Abstract][Full Text] [Related]
6. Lack of association of APOE and tau polymorphisms with dementia in Parkinson's disease. Ezquerra M; Campdelacreu J; Gaig C; Compta Y; Muñoz E; Martí MJ; Valldeoriola F; Tolosa E Neurosci Lett; 2008 Dec; 448(1):20-3. PubMed ID: 18930114 [TBL] [Abstract][Full Text] [Related]
7. [Association between polymorphism of alpha 1-antichymotrypsin and apolipoprotein E gene and Parkinson's disease in Shanghai Hans]. Hao Y; Xie H; Xu L Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(19):1172-5. PubMed ID: 11769703 [TBL] [Abstract][Full Text] [Related]
8. APOE alleles in Parkinson disease and their relationship to cognitive decline: a population-based, longitudinal study. Kurz MW; Dekomien G; Nilsen OB; Larsen JP; Aarsland D; Alves G J Geriatr Psychiatry Neurol; 2009 Sep; 22(3):166-70. PubMed ID: 19321880 [TBL] [Abstract][Full Text] [Related]
9. Absence of the apolipoprotein E epsilon4 allele is associated with working memory impairment in Parkinson's disease. Tröster AI; Fields JA; Paolo AM; Koller WC J Neurol Sci; 2006 Oct; 248(1-2):62-7. PubMed ID: 16769085 [TBL] [Abstract][Full Text] [Related]
10. Presence of an APOE4 allele results in significantly earlier onset of Parkinson's disease and a higher risk with dementia. Pankratz N; Byder L; Halter C; Rudolph A; Shults CW; Conneally PM; Foroud T; Nichols WC Mov Disord; 2006 Jan; 21(1):45-9. PubMed ID: 16116614 [TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E epsilon4 allele in familial and sporadic Parkinson's disease. Blázquez L; Otaegui D; Sáenz A; Paisán-Ruiz C; Emparanza JI; Ruiz-Martinez J; Moreno F; Martí-Massó JF; López de Munain A Neurosci Lett; 2006 Oct; 406(3):235-9. PubMed ID: 16904828 [TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E genotypes in hospitalized elderly patients with vascular dementia. Orsitto G; Seripa D; Panza F; Franceschi M; Cascavilla L; Placentino G; Matera MG; Paris F; Capurso C; Solfrizzi V; Dallapiccola B; Pilotto A Dement Geriatr Cogn Disord; 2007; 23(5):327-33. PubMed ID: 17374951 [TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein epsilon4 advances appearance of psychosis in patients with Parkinson's disease. Feldman B; Chapman J; Korczyn AD Acta Neurol Scand; 2006 Jan; 113(1):14-7. PubMed ID: 16367893 [TBL] [Abstract][Full Text] [Related]
14. The apolipoprotein E epsilon 4 allele increases the risk of drug-induced hallucinations in Parkinson's disease. de la Fuente-Fernández R; Núñez MA; López E Clin Neuropharmacol; 1999; 22(4):226-30. PubMed ID: 10442253 [TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E and dementia in Parkinson disease: a meta-analysis. Huang X; Chen P; Kaufer DI; Tröster AI; Poole C Arch Neurol; 2006 Feb; 63(2):189-93. PubMed ID: 16476806 [TBL] [Abstract][Full Text] [Related]
16. Combined effect of age and severity on the risk of dementia in Parkinson's disease. Levy G; Schupf N; Tang MX; Cote LJ; Louis ED; Mejia H; Stern Y; Marder K Ann Neurol; 2002 Jun; 51(6):722-9. PubMed ID: 12112078 [TBL] [Abstract][Full Text] [Related]
17. [The apolipoprotein E polymorphism in age related macular degeneration]. Nowak M; Swietochowska E; Szapska B; Marek B; Wielkoszyński T; Kozioł H; Klimek J; Kajdaniuk D; Kos-Kudła B; Ostrowska Z; Karpe J; Głogowska-Szelag J; Siemińska L Klin Oczna; 2004; 106(3 Suppl):427-8. PubMed ID: 15636224 [TBL] [Abstract][Full Text] [Related]
18. The apolipoprotein epsilon 4 allele in Parkinson's disease with and without dementia. Marder K; Maestre G; Cote L; Mejia H; Alfaro B; Halim A; Tang M; Tycko B; Mayeux R Neurology; 1994 Jul; 44(7):1330-1. PubMed ID: 8035940 [TBL] [Abstract][Full Text] [Related]
19. Protective effect of the apo epsilon2 allele in major depressive disorder in Taiwanese. Fan PL; Chen CD; Kao WT; Shu BC; Lung FW Acta Psychiatr Scand; 2006 Jan; 113(1):48-53. PubMed ID: 16390369 [TBL] [Abstract][Full Text] [Related]
20. [Evaluation of cognitive impairment in a population of patients with Parkinson's disease by means of the mini mental Parkinson test]. Parrao-Díaz T; Chaná-Cuevas P; Juri-Claverías C; Kunstmann C; Tapia-Núñez J Rev Neurol; 2005 Mar 16-31; 40(6):339-44. PubMed ID: 15795869 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]